Thomsen Vibeke Thulstrup, Nielsen Søren Saxmose, Thakur Aneesh, Jungersen Gregers
Department of Large Animal Sciences, Faculty of Life Sciences, University of Copenhagen, Grønnegårdsvej 8, 1870 Frederiksberg C, Denmark.
Vet Immunol Immunopathol. 2012 Jan 15;145(1-2):316-22. doi: 10.1016/j.vetimm.2011.11.021. Epub 2011 Dec 3.
Vaccination of cattle against Mycobacterium avium subsp. paratuberculosis (MAP) provides partial protection by delayed shedding of MAP and reduced numbers of clinically affected animals. The duration of vaccine induced immune response is not known. The primary objective of this study was therefore to characterize the long-term effect of whole-cell based vaccination against MAP on the immune response. A secondary objective was to evaluate whether immunodiagnosis of MAP and Mycobacterium bovis infections is affected by MAP vaccination. Two studies were performed: (1) A retrospective longitudinal study including 895 vaccinated and 2526 non-vaccinated dairy cows in 9 Danish dairy herds aiming at characterizing the long-term antibody-response to vaccination; and (2) a cross-sectional study of responses in the IFN-γ assay carried out in 140 vaccinated animals in two herds to evaluate the effect of vaccination on the cell-mediated immune response and to evaluate a possible interference with the diagnosis of M. bovis infections. The results showed that 37% of samples from vaccinated animals and 5% of samples from non-vaccinated animals, respectively, were test positive in the milk antibody ELISA. The prevalence of antibody responses of the vaccinated animals was relatively constant from 2 to 6 years of age, but decreased in older animals. Among the 140 vaccinated animals 88% tested positive with the IFN-γ test to johnin PPD and 50% responded to PPDb with IFN-γ production above a similar cut-off. Although Denmark is free of M. bovis, two of the vaccinated animals responded with higher IFN-γ levels when cultured with PPDb compared to PPDa. In conclusion, immunization with whole-cell MAP vaccines elicits both humoral and cell-mediated immune reactions, which may interfere with surveillance and diagnosis of both MAP and M. bovis infections using currently available tests.
给牛接种抗副结核分枝杆菌(MAP)疫苗可通过延迟MAP排出和减少临床发病动物数量提供部分保护。疫苗诱导的免疫反应持续时间尚不清楚。因此,本研究的主要目的是表征基于全细胞的MAP疫苗接种对免疫反应的长期影响。次要目的是评估MAP疫苗接种是否会影响MAP和牛分枝杆菌感染的免疫诊断。进行了两项研究:(1)一项回顾性纵向研究,纳入了丹麦9个奶牛场的895头接种疫苗和2526头未接种疫苗的奶牛,旨在表征对疫苗接种的长期抗体反应;(2)一项横断面研究,对两个牛群中140头接种疫苗的动物进行γ-干扰素检测反应,以评估疫苗接种对细胞介导免疫反应的影响,并评估对牛分枝杆菌感染诊断的可能干扰。结果显示,接种疫苗动物的样本中分别有37%和未接种疫苗动物的样本中有5%在牛奶抗体ELISA检测中呈阳性。接种疫苗动物的抗体反应患病率在2至6岁时相对稳定,但在年龄较大的动物中有所下降。在140头接种疫苗的动物中,88%的动物γ-干扰素检测对副结核菌素PPD呈阳性,50%的动物对PPDb的反应是γ-干扰素产生高于类似的临界值。尽管丹麦没有牛分枝杆菌,但与PPDa相比,有两头接种疫苗的动物在用PPDb培养时γ-干扰素水平更高。总之,用全细胞MAP疫苗免疫可引发体液免疫和细胞介导免疫反应,这可能会干扰使用现有检测方法对MAP和牛分枝杆菌感染的监测和诊断。